Dr. Christian Grätz appointed to the management of DJG

The internationally experienced pharmaceutical specialist Dr. Christian Grätz was appointed to management of DJG - Dr. Jung Group GmbH on 2012-01-02 . Dr. Christian Grätz is a pharmaceutical specialist with profound knowledge of global markets. He specializes in marketing and sales, strategic marketing, corporate partnerships and innovative concepts. He is very familiar with important indication areas such as cardiovascular system, gastro-intestinal tract, Dermatology, CNS, vaccines, immunotherapy and Gynecology.

Dr. Grätz occupied leading positions at Knoll AG and Beiersdorf AG. As Business Unit Director at Lederle Laboratories, a division of American Cyanamid Company, launches and restructuring of the group belonged to his area of responsibility. He focused on co-operations and joint ventures at AkzoNobel / Organon GmbH. Dr. Grätz was CEO of Bencard Allergie GmbH for twelve years. He was also appointed to the board of directors of the English parent company Allergy Therapeutics plc. (ATplc). Dr. Grätz has international experience in co-marketing, co-promotion and in-licensing as well as CEO of various affiliates in the European foreign countries.

In the DJG - Dr. Jung Group GmbH Dr. Christian Grätz is now responsible for the area of marketing of medicines.

Since 1988 DJG - Dr. Jung Group GmbH has been one of the leading healthcare specialists for Marketing & communication of pharmaceuticals in all phases of product life cycle. In a period of profound changes in the market, the company has also converted into a successful marketing company, to use the great opportunities in the marketing of drugs by multi-channel marketing and Closed Loop Marketing with double-digit growth rates.